Characteristics | CKD+ (N = 13) | CKD− (N = 104) | OR IC95% | P | ||
| N | (%) | n | (%) |
|
|
Sexes |
|
|
|
| 1.21 [0.90; 3.60] | 0.339 |
Male | 2 | 15.38 | 33 | 31.73 |
|
|
Female | 11 | 84.62 | 71 | 68.27 |
|
|
Age (years) |
|
|
|
| 4.17 [1.09; 20.34] | 0.017 |
≤45 | 2 | 15.38 | 52 | 50.00 |
|
|
>45 | 11 | 84.62 | 52 | 50.00 |
|
|
HBP |
|
|
|
| 2.81 [1.98; 8.04] | 0.078 |
Yes | 4 | 30.77 | 12 | 11.54 |
|
|
No | 9 | 69.23 | 92 | 88.46 |
|
|
Diabetes |
|
|
|
| 4.79 [1.08; 21.17] | 0.21 |
Yes | 1 | 7.69 | 1 | 0.96 |
|
|
No | 12 | 92.31 | 103 | 99.04 |
|
|
BMI (kg/m2) |
|
|
|
| 0.82 [0.27; 2.51] | 0.49 |
<25 | 4 | 30.77 | 37 | 35.58 |
|
|
≥25 | 9 | 69.23 | 67 | 64.42 |
|
|
WHO Clinical Stage |
|
|
|
| - | 0.857 |
Stage 1 | 3 | 23.08 | 21 | 20.39 |
|
|
Stage 2 | 5 | 38.46 | 31 | 30.10 |
|
|
Stage 3 | 4 | 30.77 | 33 | 32.04 |
|
|
Stage 4 | 1 | 7.69 | 18 | 17.48 |
|
|
Pathological proteinuria |
|
|
|
| 3.38 [1.23; 9.27] | 0.021 |
Yes | 7 | 53.85 | 23 | 22.12 |
|
|
No | 6 | 46.15 | 81 | 77.88 |
|
|
CD4 rate |
|
|
|
| 8.58 [0.31; 4.51] | 0.51 |
<200 | 7 | 53.85 | 52 | 50 |
|
|
≥200 | 6 | 46.15 | 52 | 50 |
|
|